NCT00849342View on ClinicalTrials.gov

Observational Study on Levemir® in Obese Diabetic Patients

CompletedOBSERVATIONAL
Enrollment

580

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

April 30, 2011

Study Completion Date

January 31, 2013

Conditions
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Interventions
DRUG

insulin detemir

Safety and effectiveness (weight and HbA1c) data collection in connection with the use of the drug Levemir® in daily clinical practice.

Trial Locations (2)

Unknown

Alphen aan den Rijn

SI-1000

Ljubljana

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY